What You Should Know: - Fortrea, a global contract research organization (CRO), and Medidata, a Dassault Systèmes company specializing in clinical trial solutions, announced an AI-powered partnership to increase diversity in clinical trials. - The collaboration aims to leverage Medidata's AI technology, specifically Medidata AI Intelligent Trials, to increase access to diverse patients in Fortrea-conducted clinical trials. Increase Diversity in Clinical Trails This partnership builds
Read More
Medidata
Drug Development: Allucent Expands Use of Medidata Clinical Cloud
What You Should Know: - Medidata announced that Allucent, a contract research organization (CRO) bringing innovation to biopharma companies, is expanding the global use of Medidata’s Clinical Cloud to advance its end-to-end clinical trial operations offering. - The agreement expands Allucent’s existing utilization of Medidata technologies. These include Rave EDC, eCOA, RTSM,
Read More
Medidata Expands Sensor Cloud Network
What You Should Know: - Medidata, a Dassault Systèmes company, and Boehringer Ingelheim, today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata, Medidata’s suite of patient-facing technologies focused on enhancing patient centricity and diversity in decentralized clinical trials (DCTs). - The
Read More
Medidata Launches New Clinical Operations Technologies
What You Should Know: - Today, Medidata, a Dassault Systèmes company, is announcing technology enhancements that address key issues in clinical trial management and oversight. - These enhancements are to Medidata Detect and Rave CTMS (Clinical Trial Management System), which will improve both data oversight and reporting for sponsors and contract research organizations (CROs) in two meaningful ways: how they comprehensively monitor their trial data, and how they
Read More
Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials
What You Should Know: - Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC
Read More
Medidata, Parexel Expands Partnership to Enhance Decentralized Clinical Trial Delivery
What You Should Know: - Medidata, a Dassault Systèmes company and Parexel, a global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health extends their 15-year global strategic partnership. This extension includes gaining access to Medidata’s continued innovations in clinical trial technology solutions with its unified platform, support of decentralized clinical trials (DCTs), the myMedidata patient portal, Sensor
Read More
Rho Selects Medidata’s Decentralized Clinical Trials Capabilities
What You Should Know: - Today, Medidata, a Dassault Systèmes company, announced that Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, is using Medidata to standardize its clinical trial platform for building out its decentralized clinical trial (DCT) technology offerings. This will enable Rho to provide rapid reporting of cross-domain, cross-study data in decentralized trials, where data collection methods have become more
Read More
Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery
What You Should Know: - Medidata, a Dassault Systèmes company, today announced a first-of-its-kind partnership with Labcorp using the Medidata Sensor Cloud to introduce a new model to advance the use of medical-grade sensors in clinical trials and accelerate biomarker discovery. - As part of the partnership, Medidata will receive and process medical-grade sensor data within drug, vaccine and device trials across Labcorp Drug Development’s clinical trial portfolio,
Read More
Medidata Announces Decentralized Clinical Trials Program
What You Should Know: - Today Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (DCT) Program, the most comprehensive set of unified, secure technologies that enable full decentralization across the clinical trial continuum. For the first time ever, drug, vaccine, and medical device developers (sponsors) and contract research organizations (CROs) can take advantage of the only platform offering on the market which combines: -
Read More
Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors
What You Should Know: - Clinical trials technology company Medidata has acquired the digital biomarker business of MC10. - MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing technology solutions, enhancing Medidata’s capabilities to integrate data from wearable sensors – including clinical grade metrics – in clinical trials. - With this acquisition, Medidata’s integrated offering will help provide life sciences companies and device
Read More
